Why the study?
How to manage patients with arrhythmogenic mitral valve prolapse at moderate risk of sudden cardiac death remains unclear.
Answers are grounded in this paper and cite their sources.
This case report presents a successful treatment approach for a patient with arrhythmogenic mitral valve prolapse and ventricular arrhythmias, an area where management of moderate-risk patients remains unclear.
The problem of managing of patients with mitral valve prolapse and ventricular arrhythmias — arrhythmogenic mitral valve prolapse — is quite relevant in routine clinical practice, which led to the creation in 2022 of an expert consensuses on the management of such patients. Based on the criteria, it is possible to identify a group of people at high risk of sudden cardiac death and implement measures to prevent death. How to manage patients at moderate risk of sudden cardiac death remains unclear. A clinical case of successful treatment of ventricular arrhythmias in a patient with arrhythmogenic mitral valve prolapse is presented.
No takes yet. Share an insight, caveat, or question.
Tretyakova et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: